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This report provides an updated overview of recom-
mended and mandatory vaccinations in the European 
Union (EU), Iceland and Norway, considering the dif-
ferences in vaccine programme implementation 
between countries. In 2010, the Vaccine European 
New Integrated Collaboration Effort (VENICE) network, 
conducted a survey among the VENICE project gate-
keepers to learn more about how national vaccination 
programmes are implemented, whether recommended 
or mandatory. Information was collected from all 27 
EU Member States, Iceland and Norway. In total 15 
countries do not have any mandatory vaccinations; 
the remaining 14 have at least one mandatory vaccina-
tion included in their programme. Vaccination against 
polio is mandatory for both children and adults in 12 
countries; diphtheria and tetanus vaccination in 11 
countries and hepatitis B vaccination in 10 countries. 
For eight of the 15 vaccines considered, some coun-
tries have a mixed strategy of recommended and man-
datory vaccinations. Mandatory vaccination may be 
considered as a way of improving compliance to vac-
cination programmes. However, compliance with many 
programmes in Europe is high, using only recommen-
dations. More information about the diversity in vac-
cine offer at European level may help countries to 
adapt vaccination strategies based on the experience 
of other countries. However, any proposal on vaccine 
strategies should be developed taking into considera-
tion the local context habits.
Introduction
Vaccinations are one of the most important tools of pri-
mary prevention. All countries in the European Union 
(EU) have a long tradition of implementing vaccina-
tion programmes. The level of control over diphtheria, 
Haemophilus influenzae type b (Hib) infections, hepati-
tis B, polio and tetanus is excellent in many countries [1]. 
The burden of measles, mumps, rubella, and pertussis 
decreased dramatically over the last decades, but there 
is still room for improvement in those programmes in 
many EU countries [2]. Strong efforts are being made 
to accelerate the implementation of newly introduced 
vaccines against pneumococcal, meningococcal and 
human papillomavirus disease. 
In the presence of such a large variety of vaccines on 
offer, the way vaccination programmes are organised 
differs considerably between countries. The vaccines 
included in the programme, the type of vaccine used, 
the total number of doses administered, and the timing 
of the vaccinations vary.  Vaccines can also be offered 
in many different ways: usually, the vaccines included 
in the routine (childhood) vaccination programme are 
paid for by the national healthcare system, whereas 
in some countries other vaccines need to be paid 
for up front by the recipient [3]. There are also large 
differences in whether vaccinations included in the 
national programmes are recommended or mandatory. 
Mandatory vaccination can be enforced by legislation, 
even though the term ‘mandatory’ has to be interpreted 
differently in different countries.
The Vaccine European New Integrated Collaboration 
Effort (VENICE) is a European network of experts work-
ing in the field of immunisation. All 27 EU Member 
States plus Iceland and Norway participate in VENICE. 
In each country a so called gatekeeper for VENICE is 
identified among the national experts in vaccine-
preventable diseases [4]. In 2007, VENICE conducted 
a survey on immunisation programmes. The survey 
also included some questions whether vaccinations 
were recommended or mandatory. Of the 28 participat-
ing countries, 10 reported mandatory vaccinations for 
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different vaccines in their national immunisation pro-
grammes [3]. 
In the meantime, vaccination programmes have 
changed. New vaccines have been added to the immu-
nisation programmes [5] and legislation about rec-
ommended and mandatory vaccinations may have 
changed. Therefore, the aim of this article is to provide 
an updated overview of recommended and mandatory 
vaccinations in the EU countries, Iceland and Norway, 
considering the differences in the modality of vaccine 
programme implementation between countries.
Methods
The national VENICE gatekeepers from the participat-
ing countries, the 27 EU countries plus Iceland and 
Norway, were sent a survey by email and asked to fill 
it out. The survey addressed the question whether the 
different childhood vaccinations were recommended 
(i.e. voluntary) or mandatory. A definition of ‘recom-
mended’ and ‘mandatory’ was provided in order to 
avoid misinterpretation. The following definitions were 
used:
•	Recommended: vaccination included in the 
national immunisation programme for all or some 
specific groups independent of being funded or not. 
•	Mandatory: a vaccination that every child  must receive 
by law without the possibility for the parent to choose 
to accept the uptake or not, independent of whether a 
legal or economical implication exists for the refusal. 
The gatekeepers were asked to provide information 
about childhood vaccinations against: diphtheria, Hib, 
hepatitis A, hepatitis B,  human papillomavirus (HPV), 
influenza, invasive disease caused by Neisseria menin-
gitidis serogroup C,  invasive pneumococcal disease, 
measles-mumps-rubella, (MMR), pertussis, polio, rota-
virus, tetanus, tuberculosis (with Bacillus Calmette-
Guérin, BCG) and varicella. The reply options were (i) 
recommended (for all or for people at risk), (ii) manda-
tory (for all or for people at risk), or (iii) absence of rec-
ommendation. Data were collected in November 2010. 
Data from all countries were sent to the VENICE gate-
keepers who were asked to validate them in April 2011. 
Results
In total 28 of the 29 participating countries responded 
to the survey. For four countries (Estonia, Germany, 
Luxembourg and the Netherlands) additional infor-
mation was found on the websites of the respective 
national public health institutes, which allowed the 
table for all 29 countries to be completed [6-10]. Data 
were validated from 19 countries. The results per coun-
try can be found in table 1.
  
The results according to vaccine are shown in Table 2. 
All 29 countries include vaccination against diphthe-
ria, hepatitis B, Hib, influenza, MMR, pertussis, polio 
and tetanus in their programme. In total 28 countries 
include vaccination against invasive pneumococcal 
disease in their recommendation or legislation, some 
countries only for children and others also for adults or 
risk groups. Most other vaccinations (against hepatitis 
A, HPV, invasive disease caused by Neisseria menin-
gitidis serogroup C, tuberculosis (with BCG) and vari-
cella) are considered by at least 20 of the participating 
countries. An exception is observed for rotavirus vac-
cination, which is only included in the national immuni-
sation programme for nine of the 29 countries. 
In total 15 countries do not have any mandatory vac-
cinations; the remaining 14 countries have at least one 
mandatory vaccination included in their programme. 
Vaccination against polio is mandatory for all children 
in 12 countries; diphtheria and tetanus vaccination is 
mandatory in 11 countries, and hepatitis B vaccination 
in 10 countries. For eight of the 15 vaccines considered 
here, some countries have a mixed strategy of rec-
ommended and mandatory vaccinations. Usually this 
means that the vaccination is recommended for the 
whole population, but that it is mandatory for some 
risk groups. 
Discussion
Mandatory vaccination may be considered as a way of 
improving the compliance to vaccination programmes. 
However, many programmes in Europe are effective 
even though voluntary, just with recommendations. 
In the vaccination field, legal consequences can be very 
different: they can be very strong – including pecuni-
ary penalties, difficulty to attend public schools, or 
even penal consequences for the parents – or can be 
much milder with the possibility of choosing to ‘opt-
out’. Moreover, the enforcement varies in practice. It is 
possible that in some cases penalties are only theoreti-
cal and never applied.  This information was not col-
lected in this survey because it is difficult to evaluate 
the national context and differences could exist in dif-
ferent regions of each country. 
Opinions on recommended or mandatory vaccina-
tions are divided, because several ethical issues are 
related to the subject [11,12]. Furthermore, at first sight 
there seems to be no striking difference in vaccina-
tion coverage between countries that only recommend 
certain vaccinations and countries that oblige them 
[1,12], although from studies it is known that making 
influenza vaccination mandatory for healthcare work-
ers can increase the vaccination coverage rates in this 
particular group [13]. On the other hand, in 2008 the 
Veneto region in Italy, with a population of five million, 
abolished all mandatory vaccination, and the cover-
age trend was carefully monitored. A vaccine coverage 
evaluation, performed in the region during 2010 for 
the 2008 birth cohort (the first cohort concerned by 
the change), revealed a slight decline of immunisa-
tion coverage rates for all the vaccinations mandatory 
prior to 2008 (diphtheria, hepatitis B, polio, tetanus) 
though levels remain well above the objective of 95%, 
as aimed for by the Italian National Immunisation Plan 
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table 1











caused by Neisseria 
meningitides group C
Austria RA RA RR RA R RR RA
Belgium RA RA RR MR/RAb) R RR RA
Bulgaria MA MA RR MA R RR A
Cyprus RA RA RR RA A RR RA
Czech Republic MA MA MR MA R RR RR
Denmark RA RA RR RR R RR RR
Estonia [6] RA RA RAe RA Re RAe RRe
Finland RA RA RR RR A RA A
France MA/MR/RAf RA RR MR/RAb R RR RA
Germany [7] RA RA RR RA R RR RA
Greece MA RA RA MAh R RR RA
Hungary MA MA MR MA A RR A
Iceland RA RA RR RR A RR RA
Ireland RA RA RR RA R RR RA
Italy MAj RA Al MA R RR RA/RRk
Latvia MA MA RR MA MA RR RR
Lithuania RA RA RR RA A RR RR
Luxembourg [8] RA RA RR RA R RR RA
Malta MA RA RR RA A RA A
The Netherlands [9] RA RA RR RR R RR RA
Norway RA RA A RR R RR A
Poland MA MA RR MA R RR RR
Portugal RA/MR RA A RA R RR RA
Romania MA MA RR MA R RR A
Slovakia MA MA MR/RRp MA R MR/RRo RR
Slovenia MA MA RR MA R RR RR
Spain RA RA RR/RAk RA R RR RA
Sweden RA RA A RR R RR A
United Kingdom RA RA RR RR R RR RA
A: absence of recommendation, MA: mandatory for all; MR: mandatory for people at risk; R: recommended; RA: recommended for all;  
RR: recommended for people at risk.
b  Mandatory for healthcare workers.
d RA: conjugated vaccine to children younger than two years of age.
    RR: polysaccharide vaccine to older persons.
e Not included in the national immunisation programme, but recommended by the Ministry of Social Affairs [10].
f  MA: children up to 18 months of age.
    MR: healthcare workers.
    RA: bolder than 13 years of age.
g  MA: children up to 13 years of age.
    MR: healthcare workers.
    RA: older than 13 years of age.
h No penalty exists for non-compliance.
j  One of 20 regions does not have any mandatory vaccination as of 2008.
k  Regional variability.
m Rubella: mandatory for girls by the age of 14.     
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table 1
Modality of implementation of childhood vaccination programme by country, the European Union countries, Iceland and 
Norway, 2010 (n=29)
A: absence of recommendation, MA: mandatory for all; MR: mandatory for people at risk; R: recommended; RA: recommended for all;  
RR: recommended for people at risk. 
a Mostly recommended for girls 10-17 years of age.
b  Mandatory for healthcare workers.
c  RA: children born prior to 2010 and younger than five years of age.
d  RA: conjugated vaccine to children younger than two years of age.
    RR: polysaccharide vaccine to older persons.
e  Not included in the national immunisation programme, but recommended by the Ministry of Social Affairs [10].
i  RA: from 2011.
k  Regional variability.
l  RA: only in one region.
n  RR: for children under two years of age.
o  MR: social care facilities.
    RR: children six months to 12 years of age, elderly, for some diagnoses, for some professions.
p  MR: direct contact with infectious person, some professions.
    RR: chronic liver disease, children two years of age living in bad conditions, some professions.















Austria RA RA RA RA RA RA A RR
Belgium RA RA RA MA RA RA A RR
Bulgaria MA/RAc MA MA MA RA MA MA A
Cyprus RA RA RA RA A RA RR RA/RR
Czech Republic MR MA MA MA A MA MR RR
Denmark RA/RRd RA RA RA A RA A RR
Estonia [6] RRe RA RA RA RRe RA RA RRe
Finland RA RA RA RA RA RA RR A
France RA RA RA MA/MR/RAg A MA/MR/RAf MR/RRb RR
Germany [7] RA RA RA RA A RA A RA
Greece RA RA RA MAh A MA RA RA
Hungary RA MA MA MA A MA MA A
Iceland RR/RAi RA RA RA A RA A RR
Ireland RA RA RA RA A RA RA RR
Italy RA/RRk RA RA MA A MA RR RA/RRk
Latvia MA MA MA MA MAi MA MA MA
Lithuania RR RA RA RA A RA RA RR
Luxembourg [8] RA RA RA RA RA RA RR RA
Malta RRn RAm RA MA A MA RA RR
The Netherlands [9] RA RA RA RA A RA RR A
Norway RA RA RA RA A RA RR A
Poland MR MA MA MA RA MA MA RR
Portugal RR RA RA RA A RA/MR RA A
Romania A MA MA MA A MA MA A
Slovakia MA MA MA MA A MA MA A
Slovenia RR MA MA MA RA MA RR RR
Spain RA/RRk RA RA RA A RA Al RA/RRk 
Sweden RA RA RA RA A RA RR A
United Kingdom RA RA RA RA A RA RR RR
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[14]. The evaluation of this experience, over time, may 
lead to legislative changes at national level [15]. Further 
research and reports of experiences are needed to see 
if a relation exists between voluntary or mandatory 
vaccination programmes, and vaccination coverage. 
In countries where both recommended and mandatory 
vaccinations  are part of the national immunisation 
plan (i.e. France, Greece, Italy, Malta) vaccines against 
pertussis, measles-containing vaccines  and vaccines 
against Hib are recommended, not mandatory,  and the 
coverage is still very high [16]. Thus the label ‘manda-
tory’ is not the only driver behind achieving a high vac-
cination coverage in these countries and many other 
factors can play a role such as the use of combined vac-
cines, prices for the recipient, kind of offer, information 
and promotional campaigns. The results of our survey 
show that there are several differences among partici-
pating countries. Immunisation strategies range from 
only voluntary vaccinations in the programme to an 
almost completely mandatory vaccination programme, 
and everything in between. The reasons behind such 
wide differences are probably both historical and cul-
tural rather than evidence-based. Differences in costs 
for recipients and the kind of vaccination offer, whether 
active or passive, also exist. These aspects have been 
explored through other, disease-specific, surveys per-
formed by VENICE [4]. 
The issue of mandatory versus recommended vac-
cinations has been widely discussed in Europe. The 
situation might change over the coming years follow-
ing the example of countries where high coverage is 
achieved, taking advantage of communication strate-
gies and the awareness of the citizen for public health 
problems and relative solutions.  
In conclusion, a national healthcare system should pro-
mote and actively offer those vaccines that have been 
proven to be safe, effective, and with a positive pub-
lic health impact. In a world where people trust health 
authorities, more compliance with national recommen-
dations can be established. This would not only ben-
efit the health of citizens, but also support the overall 
effectiveness of a vaccination programme through the 
herd immunity effect.
However, communication of the risks and of advan-
tages and disadvantages resulting from large immu-
nisation programmes is a very sensitive issue and any 
decision about a proposal for vaccine strategies should 
be elaborated in agreement with tradition and cultural 
habits.
In this quick survey a recommended vaccination was 
considered to be a ‘vaccine included in the national 
immunisation plan but not mandatory’. Some coun-
tries may not have a unique official document for 
recommended vaccinations and therefore it may not 
be straightforward to categorise a vaccine as recom-
mended or not. A different use of the term ‘recom-
mended’ could also explain some differences to the 
table 2







Diphtheria 29 16 11 2
Haemophilus influenzae type B 29 21 8 0
Hepatitis A 25 22 2 1
Hepatitis B 29 17 10 2
Human papillomavirus 23 22 1 0
Influenza 29 28  NM 1
Invasive disease caused by Neisseria meningitides serogroup C 22 22  NM 0
Invasive pneumococcal disease 28 23 4 1
Measles-mumps-rubella 29 21 8 0
Polio 29 16 12 1
Pertussis 29 21 8 0
Rotavirus 9 8 1 0
Tetanus 29 16 11 2
Tuberculosis (with Bacillus Calmette-Guérin) 23 15 7 1
Varicella 20 19 1 0
MA: mandatory for all; MR: mandatory for people at risk; NM: not mandatory in any of the countries in the study; RA: recommended for all; RR: 
recommended for people at risk.
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programme reported on the World Health Organization 
website [17]. 
Meanwhile more information about the diversity in 
vaccine offer at European level may help countries to 
adapt vaccination strategies based on the experience 
of other countries. In this way it is possible also to 
improve the vaccine offer to the citizen and to increase 
the awareness of European citizens about the impor-
tance of vaccination for public health and the underly-
ing evidence for the strategies chosen. The availability 
of comparable vaccination coverage data for all the 
Member States will help this process.
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